Gingko Biloba Leaves Extract
Natural health product licensed in Canada
- Licence holder
- Immune System Managements Inc.
- NPN or DIN-HM
- 80003085
- Status
- Active licence
- Licence date
- 29 July 2008
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ginkgo biloba Source : Feuille(s) Potency : 24 % Flavone glycosides | 20 mg | Not calculated |
| Ginkgo biloba Source : Feuille(s) Potency : 6 % Terpene lactones | Not specified | Not calculated |
Non-medicinal ingredients
Benzoate de potassium, Glycérine, (p)-hydroxybenzoate de propyle, Parahydroxybenzoate de méthyle, Eau, Benzoate de sodium, Alcool
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 mL | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Supports cognitive function in an aging population.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Hypersensitivity to Ginkgo biloba preparation. Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding.
- Effets indésirables connus
Very seldom stomach or intestinal upsets, headache or allergic skin rash.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking medication/natural health products for lowering blood pressure, thinning blood (anticoagulants/antiplatelets), for diabetes and/or seizures. Do not use 7 days before or after surgery and/or if you have a bleeding disorder. Do not use if pregnant or breastfeeding.
Source
Official Health Canada record, licence 80003085
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.